Desmoplastic Reaction in Biopsy Specimens of T1 Stage Colorectal Cancer Plays a Critical Role in Defining the Level of Sub-Mucosal Invasion by Tomita, Shigeki et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Desmoplastic Reaction in Biopsy Specimens of
T1 Stage Colorectal Cancer Plays a Critical Role in
Defining the Level of Sub-Mucosal Invasion
Shigeki Tomita, Kazuhito Ichikawa and
Takahiro Fujimori
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/51900
1. Introduction
Observation of the mucosal crypt patterns using chromoendoscopy with magnification has
been reported to be the most reliable method for determining whether a colorectal cancer
(CRC) is early or advanced tumour. Moreover, brand-new endoscopic system have the capa‐
bility to enhance visibility by the capillary pattern, which may prove to be reliable for detec‐
tion of deep submucosal invasive CRC.
Early CRC is defined as a tumour whose invasion is limited to the mucosa or submucosa.
The endoscopic mucosal resection and endoscopic mucosal dissection (EMR/ESD) have be‐
come useful for early CRC. However, EMR/ESD is applicable only to intramucosal carcino‐
ma, and additional surgery is required if the resected lesion reveals submucosal invasion by
pathological diagnosis. Therefore, endoscopist and surgical pathologist considered that it
would be very useful to predict the depth of invasion of submucosal invasive CRC before
EMR/ESD. On the other hand, desmoplastic reaction (DR) which is characterized by the
infiltration of eosinophilic myofibroblasts in the stroma of invasive carcinoma is suggested to
be a prognostic marker in CRC patients.
Here we describe that detection of DR in pre-treatment biopsy specimens is useful for pre‐
dicting the depth of submucosal invasion and evaluation of submucosal depth with head in‐
vasion or stalk invasion in post EMR/ESD specimen is useful for predicting the lymph node
metastasis and discuss relevant issues in arriving at the correct differential diagnosis based
on histological findings for gastrointestinal endoscopist and surgical pathologist.
© 2013 Tomita et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. Correlations between lymph node metastasis and early colorectal
carcinoma
The endoscopic mucosal resection and endoscopic submucosal dissection (EMR/ESD) have
become useful for early CRC which is defined as a T1 stage tumour whose invasion is limit‐
ed to the mucosa or submucosa according to the T categories for colorectal cancer of the
American Joint Committee on Cancer (AJCC) staging system (Table 1).
Tx: No description of the tumor's extent is possible because of incomplete information.
Tis: The cancer is in the earliest stage (in situ). It involves only the mucosa. It has not grown beyond the muscularis
mucosa (inner muscle layer).
T1: The cancer has grown through the muscularis mucosa and extends into the submucosa.
T2: The cancer has grown through the submucosa and extends into the muscularis propria (thick outer muscle layer).
T3: The cancer has grown through the muscularis propria and into the outermost layers of the colon or rectum but not
through them. It has not reached any nearby organs or tissues.
T4a: The cancer has grown through the serosa (also known as the visceral peritoneum), the outermost lining of the
intestines.
T4b:The cancer has grown through the wall of the colon or rectum and is attached to or invades into nearby tissues or
organs.
Table 1. T categories for colorectal cancer of the AJCC staging system.
The endoscopic mucosal dissection (EMR: endoscopic mucosal resection and ESD: endo‐
scopic submucosal dissection) of intramucosal carcinoma is accepted as curative, as there is
almost negative of lymph node metastasis. [1-4]. However, the reported prevalence rates of
lymph node metastasis range from 6 to 12% of all patients with submucosal invasive color‐
ectal carcinoma (SICC) [3-6]. Therefore, the endoscopic mucosal dissected cases of SICC
with lymph node metastasis, and after EMR/ESD, surgical resection accompanied with
lymph node dissection is necessary.
It has been known that we should be considered be additional resection is required due
to the risk of lymph node metastasis following findings (1) massive submucosal invasion:
(2)  lymphatic/vessel  invasion;  or  (3)  poorly  differentiated  component  in  resected
EMR/ESD specimens [7, 8]. There has been no standard method of measurement of sub‐
mucosal invasion depth. Therefore, Japanese Society for Cancer of the Colon and Rectum
has  recently  demonstrated definite  for  method of  measurement  of  submucosal  invasion
depth.
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3. Ip type (pedunculated lesion) and non-Ip type (nonpedunculated
lesion) of early colorectal carcinoma
Macroscopic type (endoscopic finding) was assessed according to the macroscopic clas‐
sification of early stomach carcinoma, with minor modifications. In shortly, SICCs were div‐
ided into two lesions: pedunculated (Ip type) (Figure. 1, Figure. 2(a)) and nonpedunculated
(Non-Ip type) (Figure. 1b, Figure. 2(b)). Nonpedunculated lesion were subclassified as semi‐
pedunculated lesion (Isp type) and sessile lesion (Is type). Respectively. Ip type (pedunculat‐
ed lesion) has typically head with stalk (Figure. 1, Figure 2).
Figure 1. Schema of macroscopic (endoscopic) classification of SICCs: pedunculated(Ip type) and nonpedunculat‐
ed(Non-Ip type). Arrowhead: muscularis mucosae.: 0 µm
 
(a) (b) 
Figure 2. Histological appearance of pedunculated(Ip type) (a) and nonpedunculated(Non-Ip type) (b) on Hematoxy‐
lin and Eosin staining section.
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The method used for measurement of submucosal invasion depth (Figure. 3)
Figure 3. Algorithm of measurement of submucosal invasion depth.
Firstly, EMR/ESD resected specimens are divided into pedunculated(Ip type) and nonpe‐
dunculated(Non-Ip type). For pedunculated SICC, level 2 according to Haggitt’s classificati‐
on [9] was used as the baseline (so-called Haggitt’s line), and submucosal invasion depth
was measured as the vertical distance from this line to the deepest site of invasion. The base‐
line to distinguish between head invasion, (Figure. 4(a)) and stalk invasion, (Figure. 4(b)). In
head invasion, submucosal invasion depth was regarded as 0 µm. When the deepest portion
of invasion was located below the baseline, the case was defined as a stalk invasion and the
vertical distance from this line to the deepest portion of invasion was utilized as submucosal
invasion depth.
Colonoscopy and Colorectal Cancer Screening - Future Directions164
On the other hand, nonpedunculated and when the muscularis mucosae could be identified
in hematoxylin and eosin stain, the muscularis mucosae was used as baseline and the verti‐
cal distance from this line to the deepest site of invasion represented submucosal invasion
depth, (Figure. 4(c))., however, when the muscularis mucosae could not be identified, the su‐










Figure 4. Schema of measurement of submucosal invasion depth. Ip type with head invasion (a) and stalk invasion (b),










Figure 5. Histological findings with depth of submucosal invasion (µm). Ip type with head invasion: 0 µm (a) and stalk
invasion: X µm (b), non-Ip type with musucular mucosae: Y µm (c) and without musucular mucosae: Z µm (d) on Hem‐
atoxylin and Eosin staining section
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4. Correlations between lymph node metastasis and depth of submucosal
invasive colorectal carcinoma
The Japanese collaborative retrospectively study for 865 SICCs. This nationwide survey not on‐
ly represents a first for Japan, but reviewing the literature using PubMed revealed no similar
surveys from anywhere in the world at that time [3] This study reported that pedunculated (Ip
type) SICC, rate of lymph node metastasis was never in head invasion cases and stalk invasion
cases with submucosal invasion depth < 3000 µm if lymphatic invasion was negative (Table 2).
And, For nonpedunculated (non-Ip type) SICC, rate of lymph node metastasis was also 0%
if submucosal invasion depth was <1000 µm (Table 3). In multivariate analysis, SM depth
<1000µm (P <0.006), sprouting (P <0.002), and lymphatic invasion (P<0.0001) represented
significant risk factors, with odds ratios of 5.404, 2.276, and 4.691, respectively. Several priv‐
iously reports suggested that prognosis in patients with early colorectal carcinoma based on
Haggitt’s classification, finding that level 4 which is carcinoma invading the submucosa of
the bowel wall below the stalk of the polyp but above the muscularis propria, represented
the most important factor for lymph node metastasis [9, 10]. Therefore, these results re‐
vealed that submucosal invasion could be an important of predicting lymph node metastasis
potential.
Histological type at the
deepest portion
LNM (+) Ly (+) V (+) Sp (+) wel, mod por
SM depth (µm) (%) (%) (%) (%) (%) (%)
X=0 (n=53) 3 (5.7) 15 (28.3) 9 (17.0) 15 (28.3) 51 (96.2) 2 (3.8)
0 <X<500 (n=10) 0 (0) 2 (20.0) 0 (0) 3 (33.3) 10 (100) 0 (0)
500≤X<1000 (n=7) 0 (0) 1 (14.3) 0 (0) 2 (28.6) 7 (100) 0 (0)
1000≤X<1500 (n=11) 1 (9.1) 2 (18.2) 3 (27.3) 7 (63.6) 11 (100) 0 (0)
1500≤X<2000 (n = 7) 1 (14.3) 4 (57.1) 0 (0) 5 (71.4) 7 (100) 0 (0)
2000 ≤X<2500 (n= 10) 1 (10.0) 4 (40.0) 3 (30.0) 1 (10.0) 9 (90.0) 1 (10.0)
2500≤X< 3000 (n= 4) 0 (0) 0 (0) 2 (50) 1 (25.0) 4 (100) 0 (0)
3000 ≤X<3500 (n= 9) 2 (22.2) 4 (44.4) 3 (33.3) 5 (55.6) 8 (88.9) 1 (11.1)
3500 ≤X (n= 30) 2 (6.7) 9 (30.0) 10 (33.3) 10 (33.3) 28 (93.3) 2 (6.7)
SICC, submucosal invasive colorectal carcinoma; SM depth, depth of submucosal invasion of SICC; LNM, lymph node
metastasis; Ly, lymphatic invasion; V, venous invasion; Sp, sprouting; wel, well-differentiated adenocarcinoma; mod,
moderately differentiated adenocarcinoma; por, poorly differentiated adenocarcinoma
Table 2. Relationship between clinicopathological factors and the rate of lymph node metastasis according to SM
depth in pedunculated (Ip type) SICC (adapted from [3])





LNM (+) Ly (+) V (+) Sp (+) wel, mod por Identified
Not
identified
SM depth (µm) (%) (%) (%) (%) (%) (%) (%) (%)
0 <X<500
(n=65)
0 (0) 5 (7.7) 3 (4.6) 9 (13.8) 64 (98.5) 1 (1.5) 64 (98.5) 1 (1.5)
500≤X<1000
(n=58)
0 (0) 12 (20.7) 7 (12.1) 7 (12.1) 58 (100) 0 (0) 51 (87.9) 7 (12.1)
1000≤X<1500
(n=52)
6 (11.5) 16 (30.8) 12 (23.1) 16 (30.8) 51 (98.1) 1 (1.9) 36 (69.2) 16 (30.8)
1500≤X<2000
(n = 82)
10 (12.2) 27 (32.9) 16 (19.5) 37 (45.1) 82 (100) 0 (0) 48 (58.5) 34 (41.5)
2000 ≤X<2500
(n= 84)
13 (15.5) 28 (33.3) 21 (25.0) 42 (50.0) 78 (92.9) 6 (7.1) 31 (36.9) 53 (63.1)
2500≤X< 3000
(n= 71)
8 (11.3) 29 (40.8) 16 (22.5) 38 (53.5) 71 (100) 0 (0) 20 (28.2) 51 (71.8)
3000 ≤X<3500
(n= 72)
5 (6.9) 26 (36.1) 15 (20.8) 35 (48.6) 69 (95.8) 3 (4.2) 16 (22.2) 56 (77.8)
3500 ≤X
(n= 240)
35 (14.6) 92 (38.3) 74 (30.8) 133 (55.4) 237 (98.8) 3 (1.2) 48 (20.0) 192 (80.0)
Table 3. Relationship between clinicopathological factors and the rate of lymph node metastasis according to SM
depth in nonpedunculated (non-Ip type) SICC (adapted from [3])
Suprisingly, Japanese collaborative retrospectively nationwide survey shows both of Ip type
(pedunculated lesion) and non-Ip type (nonpedunculated lesion) of early colorectal carcino‐
ma with rate of lymph node metastasis was also 0% if submucosal invasion depth was <1000
µm (Table 4). It is easy to measure one southern micrometer using by small ruler under mi‐
croscopy for surgical pathologist. When if submucosal invasion depth was 1000 µm ≤, surgi‐
cal pathologist should be advice to gastrointestinal endoscopist. And recently Japanese
large-scale multicenter retrospectively study for 384 (head invasion: 240, stalk invasion: 144)
pedunculated (Ip type) SICCs demonstrated that incidence of lymph node metastasis was
3.5%. the incidence of lymph node metastasis was 0.0% inpatients with head invasion, as‐
compared with 6.2% in patients with stalk invasion (Tabel 4). Pedunculated type early inva‐
sive colorectal cancers pathologically diagnosed as head invasion can be only treated by
endoscopic resection.
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SM depth X (µm) Ip type Non-Ip type
n pN positive (%) n pN positive (%)
head invasion (X=0) 53 3(5.7)*
0 < X < 500 10 0(0) 65 0(0)
500 ≤ X < 1000 7 0(0) 58 0(0)
1000 ≤ X < 1500 11 1(9.1)* 52 6(11.5)
1500 ≤ X < 2000 7 1(14.3)* 82 10(12.2)
2000 ≤ X < 2500 10 1(10.0)* 84 13(15.3)
2500 ≤ X < 3000 4 0(0) 71 8(11.3)
3000 ≤ X < 3500 9 2(22.2) 72 5(6.9)
3500 ≤ X 30 2(6.7) 240 35(14.6)
Ip type: pedunculated lesion. Non-Ip type: nonpedunculated lesion
*: vessels invasion
Table 4. Relationship between clinicopathological factors and the rate of the lymph node metastasis according to SM
depth (summarized of Table 2 and 3, adapted from [11]. English translated version]
Head invasion Stalk invasion Total
Lymph node metastasis n (%) 0 ⁄101 (0) 8 ⁄129 (6.2) 8 ⁄230 (3.5)
95% CI (%) 0.00–3.60P 2.70–11.90 1.50–6.70
*P = 0.02
Recurrence n (%) 0 ⁄219 (0) 1 ⁄121 (0.8) 1 ⁄340 (0.3)
95% CI (%) 0.00–1.70 0.02–4.50 0.01–1.60
**P = 0.72
Lymphovascular invasion†, n (%) 35 ⁄240 (15) 55 ⁄144 (38) 90 ⁄384 (23)
Lymphatic invasion, n (%) 21 (9) 33 (23) 54 (14)
Venous invasion, n (%) 16 (7) 37 (26) 53 (14)
Poorly differentiated component, n (%) 26 ⁄240 (11) 26 ⁄144 (18) 52 ⁄384 (14)
Lymphatic and ⁄or venous invasion. CI, confidence interval
Table 5. Histopathological characteristics of 384 cases of pedunculated type early invasive colorectal cancer (adapted
from [12])
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5. The treatment of colorectal carcinoma with submucosal invasion state
after endoscopic resection
Many new treatment methods have been developed over the last few decades. The Japanese
Society for Cancer of the Colon and Rectum guidelines 2010 for the treatment of colorectal
cancer (JSCCR Guidelines 2010 [13]) have been prepared to show standard treatment strat‐
egies for submucosal invasive colorectal cancer (Figure. 6).
Figure 6. Guide line for the treatment of colorectal carcinoma with submucosal invasion state after endoscopic resec-
tion. (adapted from JSCCR Guidelines 2010 [13] with minor modifications );; Pap: papillary adenocarcinoma, Tub: tub‐
ular adenocarcinoma, Por: poorly differentiated adenocarcinoma, Sig: signet-ring cell carcinoma, Muc: mucinous
adenocarcinoma, SM: submucosal invasion, Budding: tumor budding. The tumor budding denotes that at the invasion
front of colorectal adenocarcinomas tumour cells, and the potential of tumour budding as a prognostic factor
(G1:Grade 1 to G3: Grade 3) for routine surgical pathology [14,15])
 




Figure 7. Endoscopic, stereomicroscopic, macroscopic findings of the early colorectal carcinoma. Endoscopic finding of
the pedunculated(Non-Ip) type (a), several pits are arranged irregularly in the stereomicroscopic view (b), macroscopic
appearance of SICC, post formalin-fixed. Most of the endoscopic detectable lesions were the irregular elevated type
macroscopically. (White bar: mucosal invasion, Red bar: submucosal invasion) (c),
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6. Detection of desmoplastic reaction in biopsy specimens of colorectal
cancer
Early CRC, including submucosal invasive colorectal carcinoma (SICC), is defined as a tumor
whose invasion is limited to the mucosa or submucosa. The endoscopic resection (EMR/ESD)
have been useful for early CRC. However, endoscopic resection is applicable only to intramu‐
cosal carcinoma (Tis stage tumor), and additional surgery is required if the resected specimen
reveals submucosal invasion by pathological diagnosis. However, the study of Japanese Soci‐
ety for Cancer of the Colon and Recum have recently demonstrated that the depth of submu‐
cosal invasion is closely correlated with the prevalence of lymph node metastasis in patients
with SICC (See. Correlations between lymph node metastasis and early colorectal Carcinoma).
Therefore, gastrointestinal endoscopist and surgical pathologist considered that it would be
very useful to predict the depth of invasion of SICC before endoscopic resection for case se‐
lection. New endoscopic systems are possible to predict submocosal invasion depth without
biopsy. However, these developed systems have not been used in everywhere. On the other
hand, the stromal change associated with carcinoma invasion has been called desmoplastic
reaction (DR), desmoplasia, and cancer-associated fibroblast. Reported incidence of the DR
is suggested to be a prognostic marker in CRC patients [16, 17]. Recently, JSCCR studies
have been assessed the DR in pretreatment biopsy specimens of SICRC to predict the sub‐
mucosal depth in retorospective and prospective study.
The DR is characterized by modifications in the composition of stromal cells and extracellu‐
lar matrix (ECM) components with eosinophilic change [18, 19] (Figure. 8). The main pro‐
ducers of many ECM compounds and represent the major cellular component including DR
that often show differentiated phenotype with expression of the smooth muscle actin, plate‐
let derived growth factor receptor- type I collagen [18, 20, 21].
The presence and histological findings of DR in biopsy specimens were evaluated by pathol‐
ogists at each respective institute and the criteria for assessment of DR established in con‐
sensus meeting among JSCCR members including us. (Table 6).
Figure 8. Histological appearance of desmoplastic reaction (DR). Note the growth of eosinophilic spindle cells
(myofibroblasts.*) with submucosal invasive carcinoma component on Hematoxylin and Eosin staining section.
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1) Existence of carcinoma is required for detection of DR.
2) The histological findings of infiltrating carcinoma do not signify the presence of DR.
3) DR contains areas of collagen fiber accumulation and myofibroblast proliferation, but inflammatory infiltration does
not signify the presence of DR.
4) All histological findings were determined by HE stain alone; detection of DR does notrequire the use of any special
stains.
DR, desmoplastic reaction.
Table 6. Criteria for detection of desmoplastic reaction (adapted from [22])
A retorospective study for detection of desmoplastic reaction in biopsy specimens of early
colorectal cancer reported that 359 patients with SICRCs, who had undergone surgical or en‐
doscopic mucosal resection, were analysed [23]. For pedunculated (Ip type) SICRCs was not
significantly related to submucosal depth. However, for nonpedunculated (non-Ip type) the
prevalence of DR in pretreatment biopsy specimens was significantly related to submucosal
depth. When nonpedunculated(non-Ip type) SICRCs were further divided using a specific
cut off value of 1000 µm for submucosal depth, the positivity ratio of DR in pretreatment
biopsy specimens was significantly higher in SICRCs with an submucosal depth of 1000 µm
than in cases where the submucosal depth was <1000 µm (Table 7). Detection of DR in pre‐
treatment biopsy specimens is useful for the prediction of submucosal depth in nonpedun‐
culated (non-Ip) SICRCs,
Depth of submucosal invasion (µm) Pedunculated SICRC Nonpedunculated SICRC
DR (-) (%) DR (+) (%) DR (-) (%) DR (+) (%)
X<1000 3 (37.5) 5 (62.5) 30 (65.2) 16 (34.8)
1000 ≤ X < 2000 1 (50.0) 1 (50.0) 25 (56.8) 19 (43.2)
2000 ≤ X < 3000 5 (100) 0 (0.0) 22 (27.5) 58 (72.5)
3000 ≤ X < 4000 3 (33.3) 6 (66.7) 20 (29.9) 47 (70.1)
4000 ≤ X < 5000 0 (0.0) 1 (100) 11 (31.4) 24 (68.6)
5000 ≤ X < 6000 1 (100) 0 (0.0) 10 (43.5) 13 (56.5)
6000 ≤ X < 7000 2 (100) 0 (0.0) 5 (55.6) 4 (44.4)
7000 ≤ X < 8000 0 (0.0) 2 (100) 0 (0.0) 4 (100)
8000 ≤ X < 9000 0 (0.0) 0 (0.0) 4 (44.4) 5 (55.6)
9000 ≤ X < 10000 0 (0.0) 0 (0.0) 0 (0.0) 4 (100)
10000 ≤X 1 (50.0) 1 (50.0) 2 (33.3) 4 (66.7
Table 7. Relationship between depth of submucosal invasion and DR in biopsy specimens of patients with SICRCs -
retorospective study - (adapted from [23])
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After retorospective study [22], same study group confirmed verification of patients SICRC
with 112 nonpedunculated (non-Ip type) cases. Finally, nonpedunculated (non-Ip type) case
of the prevalence of DR was significantly correlated with submucosal depth. The sensitivity
and specificity of detection of DR for prediction of pSM2 (tumor invasion <1000 µm) in non‐
pedunculated SICRC were 68.6% and 92.0%, respectively.
Additionally, receiver operating characteristic (ROC), analysis confirmed 950 µm as the best
diagnostic cut-off value of submucosal depth for DR detection, and 50 µm, which is the dif‐
ference between the value of 950 µm as determined by cut off value (COV) and 1000 µm, the
defining value of pSM2, is an acceptable measurement error range.
In statistics and diagnostic testing, positive predictive value (PPV) is the proportion of pa‐
tients with positive test results who are correctly diagnosed, on the other hand, negative
predictive value (NPV) is negative test results. Both of PPV and NPV are critical measure of
the performance of a diagnostic method. In this studies revealed that PPV:0.93, NPV:0.59 in
pedunculated and PPV:0.95, NPV:0.59 in nonpedunculated type. These results provide a ba‐
sis for assessment of DR as a good indicator of pSM2. (Table 8).
Depth of submucosal invasion Number of patients DR–negative DR–positive
pSM2 54 17 37
pM+ pSM1 27 24 3
pSM2, SM invasion ≧1000 µm; pM + pSM1, SM invasion < 1000 µm.
Sensitivity: (37/37+ 17) x 100 = 68.5%.
Specificity: (24/24+ 3) x 100 = 88.9%.
DR, desmoplastic reaction.
Depth of submucosal invasion Number of patients DR–negative DR–positive
pSM2 51 16 35
pM+ pSM1 25 23 2
pSM2, SM invasion ≧1000 µm; pM + pSM1, SM invasion < 1000 µm.
Sensitivity: (35/35+ 16) x100 = 68.6%.
Specificity: (23/23+ 2) x 100 = 92.0%.
DR, desmoplastic reaction.
Table 8. Relationship between depth of submucosal invasion and DR in biopsy specimens of patients with
pedunculated (upper part) and nonpedunculated (lower part) type - prospective study - (adapted from [22])
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7. Conclusion
In this issue, we have discussed the a critical role of pathological assessment for T1 stage color‐
ectal cancer, several problems related to the pathological diagnosis of early CRC at increased
risk of lymph node metastasis and submucosal invasion. A new endoscopic systems which
may prove to be reliable for detection of deep submucosal invasive CRC. Moreover, current en‐
doscopic resection (EMR/ESD) have become useful for early CRC, but, these resection is appli‐
cable only to intramucosal carcinoma, and additional surgery is required if the resected lesion
reveals submucosal invasion by pathological diagnosis, because prevalence rates of lymph
node metastasis about 10% of all patients with submucosal invasive colorectal carcinoma.
We believe that curative endoscopic management for early CRC may be need to accurately
pathological diagnosis of submucosal depth. Assessment of DR in pretreatment biopsy
specimen nonpedunculated (non-Ip type) and submucosal depth with head invasion or
stalk invasion in pedunculated (Ip type) for post endoscopic resection (EMR/ESD) specimen
may be useful for the clinicopathological diagnosis of colorectal carcinoma with invasion in‐
to the submucosal layer.
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